Ocular hypotensive effects of medifoxamine.

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Medifoxamine is a novel monoamine re‐uptake inhibiting antidepressive drug which preferentially inhibits dopamine reuptake. In human volunteer studies it has been found to reduce significantly intraocular pressure after single oral doses of 300‐1000 mg, and to produce a small but statistically significant miosis. Its maximal ocular hypotensive action was less than that of oral timolol 20 mg. 1992 The British Pharmacological Society

Cite

CITATION STYLE

APA

Saleh, S., & Turner, P. (1992). Ocular hypotensive effects of medifoxamine. British Journal of Clinical Pharmacology, 34(3), 269–271. https://doi.org/10.1111/j.1365-2125.1992.tb04136.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free